GuidelineJournal of gastroenterology and hepatology2026
Gastroenterological Society of Australia Position Statement on the Assessment and Management of Idiopathic Gastroparesis.
Guideline in Journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Gastroenterological Society of Australia Position Statement on the Assessment and Management of Idiopathic Gastroparesis.Journal of gastroenterology and hepatology · 2026Guideline
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundIdiopathic gastroparesis (IGP) treatment guidelines have to date focused on delayed gastric emptying as the cause of the associated symptoms of postprandial nausea, vomiting, early satiety, fullness, and pain. However the diagnostic hallmark-delayed gastric emptying-correlates poorly with symptoms, and the efficacy of treatments targeting gastric emptying is low. Clinically, there is substantial overlap with functional gastroduodenal disorders and eating disorders. As a result, current international guidelines provide limited guidance with low consensus. Recent advances support reconceptualizing IGP as a sensorimotor disorder, on a spectrum with functional dyspepsia, arising within the biopsychosocial model of disease.
objectiveTo provide clear guidance to clinicians on the assessment and management of IGP, as a sensorimotor disorder, using a multidisciplinary framework.
methodsFollowing formal review of the literature, a national multidisciplinary working group devised 20 consensus statements with a grade of evidence and strength of recommendation using a modified Delphi approach, and a suggested treatment algorithm. External review was obtained via patient representation, expert review, and public comment.
conclusionA novel treatment algorithm and 20 consensus statements are provided to guide clinicians in the multidisciplinary assessment and management of IGP as a sensorimotor disorder, alongside its overlapping comorbidities. We call for review of the current definition of IGP and a shift in research efforts to identify novel therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.